Concepedia

Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)

Anna Maria Di Giacomo, Riccardo Danielli, Luana Calabrò, Erica Bertocci, Chiara Nannicini, Diana Giannarelli, Angelo Balestrazzi, Francesco Vigni, Valentina Riversi, Clelia Miracco,

Cancer Immunology Immunotherapy · 2010 · 80 citations · 20 references

DOIFull text

Open access

Concepts

References

20

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text

, , +12

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Jedd D. Wolchok, Axel Hoos, Steven O’Day et al. · Clinical Cancer Research · 2009 · 3.2K citations

, , +17

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Giao Q. Phan, James Chih‐Hsin Yang, Richard M. Sherry et al. · Proceedings of the National Academy of Sciences · 2003 · 1.6K citations · Full text

, , +17

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

Peter Attia, Giao Q. Phan, Ajay V. Maker et al. · Journal of Clinical Oncology · 2005 · 1K citations · Full text

, , +17

Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

Kimberly E Beck, Joseph Blansfield, Khoi Q. Tran et al. · Journal of Clinical Oncology · 2006 · 834 citations · Full text

, , +17